T. Rowe Price Investment Management, Inc. Cabaletta Bio, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $166 Billion
- Q3 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 3,673,724 shares of CABA stock, worth $8.41 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,673,724
Previous 3,878,210
5.27%
Holding current value
$8.41 Million
Previous $29 Million
40.23%
% of portfolio
0.01%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding CABA
# of Institutions
126Shares Held
47.9MCall Options Held
202KPut Options Held
110K-
Jennison Associates LLC5.63MShares$12.9 Million0.02% of portfolio
-
Black Rock Inc. New York, NY4.76MShares$10.9 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY4.12MShares$9.43 Million0.1% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$6.95 Million0.03% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.76MShares$6.32 Million2.34% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $66.4M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...